human resource and
play

Human Resource and FDI in Costa Rica "Inversiones Extranjeras - PowerPoint PPT Presentation

Human Resource and FDI in Costa Rica "Inversiones Extranjeras en Amrica Latina" APRIL 21 TH , 2017| SALVADOR DADA | COO Establishment Labs is a global, privately held, high-tech medical device and aesthetics company that designs,


  1. Human Resource and FDI in Costa Rica "Inversiones Extranjeras en América Latina" APRIL 21 TH , 2017| SALVADOR DADA | COO

  2. Establishment Labs is a global, privately held, high-tech medical device and aesthetics company that designs, develops, manufactures and markets an innovative product portfolio consisting of advanced silicone-filled breast and body shaping implants.

  3. About Establishment Labs Founded in 2004 by Juan José Chacón- Quirós and family. Founders have 30+ years of experience with breast implants market. Current operations started in 2009, in Coyol Free Zone & Business Park. 350 employees in Costa Rica and 50 employees in other geographies

  4. Management Board of Directors • Rudy Mazzocchi, Executive Chairman CEO, ELENZA • Juan José Chacón-Quirós, Founder & CEO Fmr. Founder/CEO, MICROVENA, Vascular Science, CytoGenesis, IGN, OptiSTENT Silimed, Eurosilicone. • Salvador Dada, COO • Juan Jose Chacón-Quirós Allergan Founder & CEO, Establishment Labs • Antoun Nabhan, CFO Onyx Pharma (ONXX), Capnia (NASDAQ: CAPN) • Lisa Colleran • Roberto De Mezerville, VP of R&D Fmr. President, LifeCell Allergan • Olivier Tourniaire, VP of Sales APAC • David Hung, M.D. Eurosilicone (Founder), Nagor CEO and Founder, Medivation • Erik Vogenlanzeng, VP of Sales EMEA • Michael Altman INAMED, GCA Partner, Perceptive Advisors • Eddie de Oliveira, VP of Sales LATAM & Brazil Eurosilicone, Nagor, GCA • Nick Lewin • Nicolas Maurer, VP of Marketing Operations Partner, CPH Investments Beiersdorf (La Prairie, Nivea, Eucerin) • Alberto Quesada, VP of Quality & Regulatory Affairs • Ed Schutter Allergan, Boston Sci President & CEO, Arbor Pharmaceuticals, Fmr. President, Sciele • Allan Weinstein Chairman, Spiritus Pharma, Instant Medical

  5. Key Opinion Leaders: SAB & MAB Scientific Advisory Board Medical Advisory Board • Marcos Sforza, MD • Robert Langer, PhD Medical Director THG David H. Koch Prof. MIT • Hilton Becker, MD • Ardeshir Bayat, MD & PhD Creator of the adjustable implant Director Plastic Surgery Research Former Mentor advisor Center at Univ. of Manchester • Manuel Chacon-Quiros, MD • Brian Kinney, MD & Eng Motiva educator Industry expert • Dennis Hammond, MD • Benjamin Lewin, PhD Former Mentor KOL and PI Founder, Cell • John Hancock, Eng Industry expert

  6. About Establishment Labs Establishment Labs Holdings, Inc. (BVI) Establishment Labs, Motiva Asia JAMM Tech, Inc. Motiva USA, LLC Motiva Europe Motiva Brasil IP Vault S.A (Hong Kong) (EUA, Minneapolis) (EUA, Delaware) (Belgium/Germany) (Brazil) (Switzerland) (Costa Rica - HQ)|

  7. About Establishment Labs EMEA Presence in more than 60 countries in the Europe, Asia, APAC Middle East, Africa, Asia Pacific and Latin America. Currently performing the regulatory process to enter into LATAM the US and China markets.

  8. Our mission is to deliver the next generation of high-tech devices that address critical and unmet needs in breast aesthetics.

  9. About Establishment Labs Core competencies include advanced material development, 3D simulation, and silicone manufacturing. Highly specialized workforce to ensure craftsmanship in manufacturing. Strategic alliances for product and platform developments.

  10. FDI & Human Resource Statistics

  11. FDI Evolution and Growth FDI inflows have grown an average of 5.0% yearly since 2006. In 2016, FDI accounted for 4.8% of GDP Costa Rica ranks among the top countries in Latin America. Source: CINDE based on data from BCCR and IMF 2017.

  12. Exports Evolution and Growth Since the year 2000 exports of goods and Services have grown at an average annual Rate of 5.1% . Goods: 3.3% Services: 8.3% In 2016, exports and imports of goods and Services represented 64% of GDP . Source: CINDE based on data from BCCR and PROCOMER 2017.

  13. Diversification of Exports Costa Rica has experienced a consistent diversification in its exports. Medical Devices was the major industrial export In 2016. Every year more Lifescienses and Advanced Manufacturing companies invest in the country. Source: CINDE based on data from PROCOMER 2017.

  14. Medical Devices Exports Medical Devices tripled exports since 2007 Source: CINDE based on data from PROCOMER and Duke University Trade Classification 2017.

  15. People make the difference Costa Rica invests in two major pillars of growth - Health: 9.9% of GDP - Education: 7.36% of GDP Costa Rica in among the healthiest and most educated countries in the world. 35% of the population in 15 to 35 years old. Source: CINDE, 2017.

  16. A young, educated labor pool of talented people Source: CINDE based on data from The National Statistics Institute, 2017.

  17. Quality of Education Costa Rican education system is 1 in Latin America And ranks 27 th highest in the world , above nations such as France, India, China and Philippines. Costa Rica is the preferred destination of US Students studying abroad Source: CINDE based on data from World Economic Forum, Executive Opinion Survey, The Global Competitiveness Report 2016-2017.

  18. Graduates in Health Programs Since 2010, a fifth of the new careers were focused on health sciences. Graduates have been growing since 2010 at a rate of 6.1% Most graduates pursue a Post Graduated degree. Source: CINDE based on data from CONARE & Universities Registry Departments 2016/El Financiero, July 2016. 2016-2019 Forecasts..

  19. Graduates in Engineering programs Source: CINDE based on data from CONARE & University Registry Department. Source: CINDE based on data from World Economic Forum, Executive Opinion Survey, The Global Competitiveness Report 2016-2017.

  20. There is high offer of Technical Area graduates Source: CINDE based on data from INA 2015.

  21. However…

  22. Our Challenges: Self Training in Worldwide Regulatory and Quality Standards: • ISO`s: 13485, 9001, 14630, 14607, 10993. • GMP`s: FDA 21 CFR, European CE MARK, • Australian TGH, MDR Canada, Brazilian RDC 16, Japanese MD. Research, Development & Innovation: • Development of Class III medical devices Design Files. • Management of worldwide clinical studies and PMS. • Scientific development: studies with University of Manchester, University of Innsburck, University of Montana, MIT, Sapienza University of Rome & Universidad de Costa Rica • Publications Intellectual Property: • Trademarks. • Trade secrets. • Brand management. • Patents.

  23. Patent Portfolio Product Development IP Components Alliances with KOL´s . LICENSED Title: IMPLANT BARRIER INDICATOR Title: BREAST IMPLANTS WITH INTEGRATED TRANSPONDERS Title: GLUTEAL IMPLANTS Country Application Official No. Date Filed Date Country Application Official No. Date Filed Date Number Assignmen Country Application Official No. Date Filed Date Number Assignmen t Recorded Number Assignmen t Recorded United States 61975474 - 04/04/2014 Provisional t Recorded United States 61701910 - 17/09/2012 Not yet of America Mexico PA/a/2005/0 279235 18/02/2005 21 Sept. of America recorded 02006 2010 Title: HIGH TEMPERATURE TRANSPONDERS Title: GRAVITY SENSITIVE BREAST IMPLANTS Country Application Official No. Date Filed Date Country Application Official No. Date Filed Date Number Assignmen Number Assignmen t Recorded t Recorded United States 61701260 - 14/09/2012 Not yet United States 13412221 - 05/03/2012 Not yet of America recorded of America recorded

  24. Patents New Potential Materials LICENSED. Title: SILICON-BASED POLYCARBONATES Title: PROCESS FOR THE PURIFICATION OF POLYETHERS Country Application Official No. Date Filed Date Assignment Country Application Official No. Date Filed Date Number Recorded Number Assignment Australia 75124/98 734927 20/05/1998 7 June 2011 Recorded Australia 80933/98 741367 29/06/1998 7 June 2011 Germany 98922507.3 69808076.9-08 20/05/1998 4 July 2011 France 98922507.3 984997 20/05/1998 Not yet recorded United Kingdom 98922507.3 984997 20/05/1998 Not yet recorded Title: SOFT TISSUE IMPLANT Italy 98922507.3 984997 20/05/1998 Not yet recorded Country Application Official No. Date Filed Date Number Assignment Japan 11-500003 4593694 20/05/1998 Not yet recorded Recorded Australia 2006349361 2006349361 10/10/2006 20 May 2011 United States of 10/219732 7026423 20/05/1998 15 June 2011 America Brazil PI0622149-1 PI0622149-1 10/10/2006 Not yet Title: GELS recorded Country Application Number Official No. Date Filed Date Assignment Canada 2665945 2665945 10/10/2006 7 July 2011 Recorded Australia 2005289374 2005289374 28/09/2005 20 May 2011 European 6790358.3 6790358.3 10/10/2006 29 June 2011 Patent Office Brazil PI 0515934-2 PI 0515934-2 28/09/2005 Not yet recorded Japan 2009-531692 2009-531692 10/10/2006 Not yet China 200580032323.8 200580032323.8 28/09/2005 Not yet recorded recorded European Patent 5791328.7 5791328.7 28/09/2005 29 June 2011 United States of 12/444676 12/444676 10/10/2006 15 June 2011 Office America India 1026/KOLNP/2007 1026/KOLNP/2007 28/09/2005 Not yet recorded Japan 2007-533824 2007-533824 28/09/2005 Not yet recorded United States of 11/663870 11/663870 28/09/2005 15 June 2011 America

Recommend


More recommend